Andrew Hirsch

2019 - Agios Pharmaceuticals

In 2019, Andrew Hirsch earned a total compensation of $4.2M as Chief Financial Officer at Agios Pharmaceuticals, a 35% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$202,693
Option Awards$1,609,989
Salary$500,476
Stock Awards$1,923,145
Other$12,528
Total$4,248,831

Hirsch received $1.9M in stock awards, accounting for 45% of the total pay in 2019.

Hirsch also received $202.7K in non-equity incentive plan, $1.6M in option awards, $500.5K in salary and $12.5K in other compensation.

Rankings

In 2019, Andrew Hirsch's compensation ranked 2,770th out of 13,971 executives tracked by ExecPay. In other words, Hirsch earned more than 80.2% of executives.

ClassificationRankingPercentile
All
2,770
out of 13,971
80th
Division
Manufacturing
997
out of 5,701
83rd
Major group
Chemicals And Allied Products
330
out of 2,200
85th
Industry group
Drugs
268
out of 1,886
86th
Industry
Pharmaceutical Preparations
198
out of 1,398
86th

Pay ratio

Andrew Hirsch's Pay$4,248,831
Median Employee's Pay$267,104
Pay Ratio

16

to 1

In 2019, the annual total compensation of Andrew Hirsch was $4,248,831.

The annual total compensation of the median employee at Agios Pharmaceuticals was $267,104.

The ratio of Andrew Hirsch's pay to the pay of median employee was therefore 16 to one.

Source: SEC filing on April 16, 2020.

Hirsch's colleagues

We found five more compensation records of executives who worked with Andrew Hirsch at Agios Pharmaceuticals in 2019.

2019

Jacqualyn Fouse

Agios Pharmaceuticals

Chief Executive Officer

2019

Christopher Bowden

Agios Pharmaceuticals

Chief Medical Officer

2019

Scott Biller

Agios Pharmaceuticals

Chief Scientific Officer

2019

Jonathan Biller

Agios Pharmaceuticals

Chief Legal Officer

2019

David Schenkein

Agios Pharmaceuticals

Chief Executive Officer

News

You may also like